SKI Market

Indian Indices

Nifty

22,200.55 -17.30
(-0.08%)

Sensex

72,987.03 -117.58
( -0.16%)

Bank Nifty

47,687.45 -172.00
( -0.36%)

Nifty IT

33,117.40 -5.45
( -0.02%)

Global Indices

Nasdaq

16,511.18 122.94
(0.75%)

Dow Jones

39,558.11 126.60
(0.32%)

Hang Seng

19,073.71 -41.35
(-0.22%)

Nikkei 225

38,385.73 29.67
(0.08%)

Forex

USD-INR

83.51 -0.04
(-0.05%)

EUR-INR

90.06 0.08
(0.08%)

GBP-INR

104.74 0.11
(0.10%)

JPY-INR

0.54 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vaishali Pharma Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

535000

INE972X01014

42.7027609

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VAISHALI

30.1

175.85

EPS(TTM)

Face Value()

Div & Yield %

5.45

Back

vaishali pharma ltd

Vaishali Pharma standalone net profit declines 14.57% in the September 2023 quarter

Nov 08,2023

Net profit of Vaishali Pharma declined 14.57% to Rs 1.70 crore in the quarter ended September 2023 as against Rs 1.99 crore during the previous quarter ended September 2022. Sales declined 4.70% to Rs 12.57 crore in the quarter ended September 2023 as against Rs 13.19 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	12.57	13.19	-5
OPM %	21.08	19.56	-
PBDT	2.48	2.79	-11
PBT	2.36	2.65	-11
NP	1.70	1.99	-15

22,200.55 -17.30 (-0.08%)

72,987.03 -117.58 ( -0.16%)

47,687.45 -172.00 ( -0.36%)

33,117.40 -5.45 ( -0.02%)

16,511.18 122.94 (0.75%)

39,558.11 126.60 (0.32%)

19,073.71 -41.35 (-0.22%)

38,385.73 29.67 (0.08%)

83.51 -0.04 (-0.05%)

90.06 0.08 (0.08%)

104.74 0.11 (0.10%)

0.54 0.00 (-0.16%)